BackMolecular Pharmacology (USA), Overview

Molecular Pharmacology (USA), Current Cash

Latest current cash for MLPH: $1.5K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1517.00
↓ 78.78% YoYΔ $-5633.00 vs prior year quarter

Peer trimmed avg / median

Loading

Molecular Pharmacology (USA), Current Cash History

Loading

Molecular Pharmacology (USA), vs. peers: Current Cash Comparison

Loading

Molecular Pharmacology (USA), Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecular Pharmacology (USA), (MLPH) FAQ

Molecular Pharmacology (USA), (MLPH) currently reports a current cash of $1.5K as of September 2014. That compares with $7.2K in the prior-year period — down 78.8% year over year. Use the charts on this page to explore Molecular Pharmacology (USA),'s current cash history and peer comparisons.

Molecular Pharmacology (USA),'s current cash decreased from $7.2K to $1.5K — a 78.8% year-over-year decrease (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecular Pharmacology (USA), reported $1.5K in current cash as of September 2014. That compares with $7.2K in the prior-year period — down 78.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $1.5K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Pharmacology (USA),, and consider following MLPH for alerts when major investors trade the stock.